Oppenheimer & Co’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Oppenheimer & Co's BCAT Position: Q1 2026 in Review
Oppenheimer & Co reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 61% in Q1 2026, selling an estimated $456K and leaving 19,964 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.
Oppenheimer & Co first reported a position in BCAT in Q3 2021 and has held it in 19 quarters since. The position peaked at $942K in Q3 2024. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- Oppenheimer & Co held 19,964 shares of BlackRock Capital Allocation Term Trust worth $282K as of Q1 2026.
- Oppenheimer & Co sold 30,952 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $456K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1430 holding.
- Oppenheimer & Co first reported a position in BlackRock Capital Allocation Term Trust in Q3 2021 and has held it in 19 quarters since.
- Oppenheimer & Co's BlackRock Capital Allocation Term Trust position peaked at $942K in Q3 2024.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.